ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SRRK Scholar Rock Holdings Corporation

14.63
0.67 (4.80%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 498,572
Bid Price 12.95
Ask Price 14.94
News -
Day High 14.705

Low
5.56

52 Week Range

High
21.17

Day Low 13.88
Company Name Stock Ticker Symbol Market Type
Scholar Rock Holdings Corporation SRRK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.67 4.80% 14.63 19:49:36
Open Price Low Price High Price Close Price Prev Close
14.05 13.88 14.705 14.53 13.96
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
7,811 498,572 $ 14.44 $ 7,197,215 - 5.56 - 21.17
Last Trade Time Type Quantity Stock Price Currency
19:49:36 formt 1,000 $ 14.63 USD

Scholar Rock Holdings Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.05B 72.14M - 0 -165.79M -2.30 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Scholar Rock News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SRRK Message Board. Create One! See More Posts on SRRK Message Board See More Message Board Posts

Historical SRRK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week14.0515.1313.1814.14714,3040.584.13%
1 Month17.6017.649913.1114.44609,632-2.97-16.88%
3 Months14.7917.9012.8115.48821,947-0.16-1.08%
6 Months9.0021.179.0015.53878,1785.6362.56%
1 Year7.4521.175.5612.82661,9747.1896.38%
3 Years35.0044.954.32512.71483,610-20.37-58.20%
5 Years18.5170.004.32520.32447,294-3.88-20.96%

Scholar Rock Description

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States. The company's lead product candidate is SRK-015 which is a highly selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle.

Your Recent History

Delayed Upgrade Clock